Dasotraline Pediatric ADHD Study

NCT02428088 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Dasotraline
DRUG: Dasotraline
DRUG: Placebo Comparator

Sponsor

Sumitomo Pharma America, Inc.